Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP475020.RABTiHuobQW4dxy17hQXI1Hs3zEqGt8QaJCo4YfZpuviI130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475020.RABTiHuobQW4dxy17hQXI1Hs3zEqGt8QaJCo4YfZpuviI130_provenance.
• NP927625.RADesrAnDTNtXcYgfCOFxi-DdNqcwQ66BijSZWLlobNaY130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927625.RADesrAnDTNtXcYgfCOFxi-DdNqcwQ66BijSZWLlobNaY130_provenance.
• NP735656.RAUpWbBosMWj40OLpnjRTdgctWnskT2p6zk0cbM4yqkG0130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735656.RAUpWbBosMWj40OLpnjRTdgctWnskT2p6zk0cbM4yqkG0130_provenance.
• NP767928.RAVBVh4L23udTUSMz7w-GEyLVEMvwoMZ7Fr5hHaHI-oPM130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767928.RAVBVh4L23udTUSMz7w-GEyLVEMvwoMZ7Fr5hHaHI-oPM130_provenance.
• assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP419124.RAAO4_0f-WeCEXEXCXo0hdt-1mLhE3Z_uMuXTG-J4K-zM130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419124.RAAO4_0f-WeCEXEXCXo0hdt-1mLhE3Z_uMuXTG-J4K-zM130_provenance.
• NP419129.RABN-kF6cVDbR1HW6wUU_ODeBcwIWM7rPZ3hLFFZ29PQ8130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419129.RABN-kF6cVDbR1HW6wUU_ODeBcwIWM7rPZ3hLFFZ29PQ8130_provenance.
• NP419126.RAcyf1WT4I2QnQyhcf6UiJABZcCRlnNoGaZkvPJ52qd70130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419126.RAcyf1WT4I2QnQyhcf6UiJABZcCRlnNoGaZkvPJ52qd70130_provenance.
• NP419132.RAf9mcOFQJOXoNnCi_rlb3983FTJg27Hgt51ff31RgRIw130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419132.RAf9mcOFQJOXoNnCi_rlb3983FTJg27Hgt51ff31RgRIw130_provenance.
• NP851752.RAKCJBplknYwGSos2F-IaqGFrGr66aNuPT7t3P0vY5AK8130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851752.RAKCJBplknYwGSos2F-IaqGFrGr66aNuPT7t3P0vY5AK8130_provenance.
• NP419133.RAnn3dj5dxBfHqJMwB3qhSi3UaheGD-Jsnqm0yB9hX2QI130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419133.RAnn3dj5dxBfHqJMwB3qhSi3UaheGD-Jsnqm0yB9hX2QI130_provenance.
• NP419128.RAPEI0X-rzZCQMfFba9LjhHa_vSzHhXozxvQyRt_g8VQA130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419128.RAPEI0X-rzZCQMfFba9LjhHa_vSzHhXozxvQyRt_g8VQA130_provenance.
• NP419131.RAL8BAVBebQINFOjPf5a86emGwyS3K8V2LiXHWhjATQVA130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419131.RAL8BAVBebQINFOjPf5a86emGwyS3K8V2LiXHWhjATQVA130_provenance.
• NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_assertion description "[Using a cDNA microarray analysis, we previously found that exposure of a highly invasive ovarian cancer cell line HRA with bikunin, a Kunitz-type protease inhibitor, or bikunin gene overexpression markedly reduced phosphoinositide kinase (PI3K) p85 gene expression, demonstrating that PI3K may be a candidate bikunin target gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419135.RA8ELXiQgoUI_vaeZu2RUq3YX54I3_nfrPFqJzQjwRkR8130_provenance.